Related Experiment Video
Updated: Jun 1, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor
Amber B Johnson1, Bert W O'Malley
1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, United States.
Abstract:
Coactivators are a diverse group of non-DNA binding proteins that induce structural changes in agonist-bound nuclear receptors (NRs) that are essential for NR-mediated transcriptional activation. Once bound, coactivators function to bridge enhancer binding proteins to the general transcription machinery, as well as to recruit secondary coactivators that modify promoter and enhancer chromatin in a manner permissive for transcriptional activation. In the following review article, we focus on one of the most in-depth studied families of coactivators, the steroid receptor coactivators (SRC) 1, 2, and 3. SRCs are widely implicated in NR-mediated diseases, especially in cancers, with the majority of studies focused on their roles in breast cancer. We highlight the relevant literature supporting the oncogenic activity of SRCs and their future as diagnostic and prognostic indicators. With much interest in the development of selective receptor modulators (SRMs), we focus on how these coactivators regulate the interactions between SRMs and their respective NRs; and, importantly, the influence that coactivators have on the functional output of SRMs. Furthermore, we speculate that coactivator-specific inhibitors could provide powerful, all-encompassing treatments that target multiple modes of oncogenic regulation in cancers resistant to typical anti-endocrine treatments.
Insights
Steroid receptor coactivators (SRCs) are key proteins in nuclear receptor (NR) function and are implicated in cancer. Targeting SRCs may offer new treatments for endocrine-resistant cancers.
Area of Science:
- Molecular Biology
- Cell Biology
- Endocrinology
Background:
- Coactivators are non-DNA binding proteins crucial for nuclear receptor (NR)-mediated transcription.
- Steroid receptor coactivators (SRCs), including SRC-1, SRC-2, and SRC-3, are extensively studied for their roles in NR function.
- SRCs are implicated in various diseases, particularly cancers like breast cancer.
Purpose of the Study:
- To review the literature on SRCs, focusing on their oncogenic activity and potential as diagnostic/prognostic indicators.
- To explore the role of SRCs in regulating interactions between selective receptor modulators (SRMs) and NRs.
- To discuss the influence of SRCs on the functional outcomes of SRMs.
Main Methods:
- Literature review of studies on SRCs, nuclear receptors, and selective receptor modulators.
- Analysis of research supporting the oncogenic roles of SRCs.
- Examination of the impact of SRCs on SRM-NR interactions and functional output.
Main Results:
- SRCs are implicated in the oncogenic activity of NRs, especially in breast cancer.
- SRCs influence the efficacy and functional output of selective receptor modulators (SRMs).
- The literature supports the potential of SRCs as diagnostic and prognostic markers in cancer.
Conclusions:
- SRCs play a significant role in NR-mediated transcriptional activation and disease, particularly cancer.
- Understanding SRC-NR-SRM interactions is vital for developing targeted cancer therapies.
- Coactivator-specific inhibitors represent a promising therapeutic strategy for endocrine-resistant cancers.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Co-activators and Co-repressors
Co-activators and Co-repressors
Regulation of Nuclear Protein Sorting
Master Transcription Regulators
Master Transcription Regulators
